Cibenzoline: Difference between revisions
No edit summary |
No edit summary |
||
Line 39: | Line 39: | ||
==Overview== | ==Overview== | ||
'''Cibenzoline''' (or '''cifenline''') is a Class Ia [[antiarrhythmic]]. | '''Cibenzoline''' (or '''cifenline''') is a Class Ia [[antiarrhythmic]]. | ||
Revision as of 22:33, 23 July 2014
Names | |
---|---|
IUPAC name
2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
KEGG | |
PubChem CID
|
|
| |
| |
Properties | |
C18H18N2 | |
Molar mass | 262.35 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
WikiDoc Resources for Cibenzoline |
Articles |
---|
Most recent articles on Cibenzoline Most cited articles on Cibenzoline |
Media |
Powerpoint slides on Cibenzoline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cibenzoline at Clinical Trials.gov Clinical Trials on Cibenzoline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cibenzoline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cibenzoline Discussion groups on Cibenzoline Patient Handouts on Cibenzoline Directions to Hospitals Treating Cibenzoline Risk calculators and risk factors for Cibenzoline
|
Healthcare Provider Resources |
Causes & Risk Factors for Cibenzoline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cibenzoline (or cifenline) is a Class Ia antiarrhythmic.